Charmacy Pharmaceutical Co., Ltd.

HKEX:2289.HK

9.3 (HKD) • At close November 12, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Omzet 2,347.1852,134.5592,269.0742,288.21,887.0791,800.6041,993.0142,130.9511,860.7591,784.6951,708.0881,913.2582,021.9882,191.8941,903.9421,891.8321,777.9491,761.7361,635.3971,564.5331,449.526753.515
Kosten van de omzet 2,182.221,984.892,130.3612,141.1171,765.5531,698.3971,861.1042,012.8671,741.4411,698.1141,574.0211,824.9651,875.1592,109.2141,779.2021,811.5841,678.3511,680.6471,551.7841,499.4971,378.121719.405
Brutowinst 164.965149.669138.713147.083121.527102.207131.91118.085119.31886.581134.06788.293146.82982.68124.73980.24999.59881.08983.61365.03671.40534.11
Brutowinstmarge 0.070.070.0610.0640.0640.0570.0660.0550.0640.0490.0780.0460.0730.0380.0660.0420.0560.0460.0510.0420.0490.045
Onderzoek- en ontwikkelingskosten 0000000000000000000000
Algemene en administratieve kosten 23.27128.64318.8931.42318.31329.44718.95529.23816.46224.0322.47428.33225.82726.00523.49817.09421.66117.70622.67421.55615.6069.291
Verkoop- en marketingkosten 62.9459.46563.00258.93453.89751.1352.31845.2840.69541.28536.11537.836.18335.85832.2229.64322.13521.79218.50420.09815.6598.939
Verkoop-, algemene en administratieve kosten 87.0888.45982.34592.5672.48980.03871.52182.77960.26470.14858.00267.29462.89264.88354.67448.85143.79639.49841.17841.65431.26518.23
Overige kosten 38.54428.99900000000000000000-0.216-0.128-0.128
Bedrijfskosten 125.624117.45789.1435.3180.77484.88478.53390.21964.72474.68364.1274.94868.60467.87357.68146.64943.58865.31838.3641.71830.68918.102
Bedrijfsresultaat 39.34132.21251.7648.99744.4918.12656.29731.93656.1413.28971.90918.02481.05715.68468.03430.02253.43741.59142.43523.38240.1417.192
Bedrijfsresultaat ratio 0.0170.0150.0230.0210.0240.010.0280.0150.030.0070.0420.0090.040.0070.0360.0160.030.0240.0260.0150.0280.023
Totaal overige inkomsten en kosten netto -0.4130.05-16.6020.185-18.642-19.676-21.767-18.939-14.395-15.862-14.29-18.683-16.742-13.734-10.1262.0840.833-33.731-8.72-10-7.587-5.708
Inkomen voor belasting 38.92832.26235.15796.20625.848-1.5534.5312.99741.746-2.57457.618-0.65964.3151.9557.90826.85249.2297.8633.71513.38232.55311.484
Inkomen voor belasting ratio 0.0170.0150.0150.0420.014-0.0010.0170.0060.022-0.0010.034-00.0320.0010.030.0140.0280.0040.0210.0090.0220.015
Belastingkosten 12.1817.278.80526.3735.2091.2588.5693.31410.8720.42215.3140.09818.9920.61614.9467.15712.4676.7358.4813.3866.1042.373
Nettowinst 26.74724.99226.35369.83320.639-2.80825.9619.68330.873-2.15142.305-0.20745.641.84142.91919.69636.7631.12525.2349.99626.4499.111
Nettowinstmarge 0.0110.0120.0120.0310.011-0.0020.0130.0050.017-0.0010.025-00.0230.0010.0230.010.0210.0010.0150.0060.0180.012
WPA (Winst Per Aandeel) 0.250.230.240.650.19-0.0260.240.090.29-0.020.39-0.0020.420.0170.40.180.340.0140.320.120.330.11
Verwaterde WPA 0.250.230.240.650.19-0.0260.240.090.29-0.020.39-0.0020.420.0170.40.180.340.0140.320.120.330.11
EBITDA 83.43566.3961.70261.17759.85333.52969.98943.82766.04323.28283.0227.97889.54423.03474.80535.98658.95146.16246.84628.11745.1320.177
EBITDA ratio 0.0360.0310.0270.0270.0320.0190.0350.0210.0350.0130.0490.0150.0440.0110.0390.0190.0330.0260.0290.0180.0310.027